Epidemiology of hepatitis E: current status
- PMID: 19686410
- DOI: 10.1111/j.1440-1746.2009.05933.x
Epidemiology of hepatitis E: current status
Abstract
Hepatitis E, caused by infection with hepatitis E virus (HEV), is a common cause of acute hepatitis in areas with poor sanitation. The virus has four genotypes with one serotype: genotypes 1 and 2 exclusively infect humans, whereas genotypes 3 and 4 also infect other animals, particularly pigs. In endemic areas, both large outbreaks of acute hepatitis as well as sporadic cases occur frequently. These cases are usually due to genotype 1 or 2 HEV and are predominantly caused by fecal-oral transmission, usually through contamination of drinking water; contaminated food, materno-fetal (vertical spread) and parenteral routes are less common modes of infection. The acute hepatitis caused by this virus has the highest attack rates in young adults and the disease is particularly severe among pregnant women. HEV superinfection can occur among persons with pre-existing chronic liver disease. In non-endemic regions, locally acquired disease was believed to be extremely uncommon. However, in recent years, an increasing number of cases, due mostly due to genotype 3 or 4 HEV, have been recognized. These are more often elderly men who have other coexisting illnesses, and appear to be related to zoonotic transmission from pigs, wild boars and deer, either food-borne or otherwise. Also, chronic infection with genotype 3 HEV has been reported among immunosuppressed persons in these regions. A subunit vaccine has been shown to be effective in preventing clinical disease, but is not yet commercially available. Our understanding of hepatitis E epidemiology has undergone major changes in recent years, and the future may hold even more surprises.
Similar articles
-
Hepatitis E: Historical, contemporary and future perspectives.J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:72-82. doi: 10.1111/j.1440-1746.2010.06540.x. J Gastroenterol Hepatol. 2011. PMID: 21199517 Review.
-
Hepatitis E virus: the current scenario.Int J Infect Dis. 2013 Apr;17(4):e228-33. doi: 10.1016/j.ijid.2012.11.026. Epub 2013 Jan 10. Int J Infect Dis. 2013. PMID: 23313154 Review.
-
Hepatitis E.Hepatology. 2011 Dec;54(6):2218-26. doi: 10.1002/hep.24674. Hepatology. 2011. PMID: 21932388 Review.
-
Global epidemiology and medical aspects of hepatitis E.Forum (Genova). 2001 Apr-Jun;11(2):166-79. Forum (Genova). 2001. PMID: 11948361 Review.
-
Hepatitis E virus: molecular virology, clinical features, diagnosis, transmission, epidemiology, and prevention.J Med Virol. 2008 Apr;80(4):646-58. doi: 10.1002/jmv.21116. J Med Virol. 2008. PMID: 18297720 Review.
Cited by
-
Seroprevalence of hepatitis E among Iranian renal transplant recipients.Hepat Mon. 2011 Aug;11(8):646-51. doi: 10.5812/kowsar.1735143x.690. Hepat Mon. 2011. PMID: 22140389 Free PMC article.
-
Molecular characterization of hepatitis E virus ORF1 gene supports a papain-like cysteine protease (PCP)-domain activity.Virus Res. 2013 Dec 26;178(2):553-6. doi: 10.1016/j.virusres.2013.07.020. Epub 2013 Aug 23. Virus Res. 2013. PMID: 23978667 Free PMC article.
-
Plasma peptidome profiling of acute hepatitis E patients by MALDI-TOF/TOF.Proteome Sci. 2011 Feb 4;9:5. doi: 10.1186/1477-5956-9-5. Proteome Sci. 2011. PMID: 21294899 Free PMC article.
-
Disseminated inflammation of the central nervous system associated with acute hepatitis E: a case report.BMC Neurol. 2020 Oct 27;20(1):391. doi: 10.1186/s12883-020-01952-5. BMC Neurol. 2020. PMID: 33109105 Free PMC article.
-
Use of immuno-dominant epitope derived from genotype 4 as a diagnostic reagent for detecting the antibodies against Hepatitis E Virus.Virol J. 2013 Apr 25;10:131. doi: 10.1186/1743-422X-10-131. Virol J. 2013. PMID: 23618011 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources